Funding The Future: Accelerating The Long Walk To Innovation
Good ideas must be paired with good people
In Vivo spoke with two company creators working in the biotech industry about their strategies for seeking new science and their funding philosophy when building the biotechs of tomorrow.
You may also be interested in...
The UK biotech aims to raise $100m, but will need to tackle safety concerns to secure a long-term future.
Decades after it was first mentioned, the updated European patent system – which includes the Unitary Patent and the Unified Patent Court – has finally materialized. What impact will this have on originator and generic pharma?
Ferring Pharmaceuticals’ US CSO Elizabeth Garner talks to In Vivo about the future of fertility and where investment should be heading to make a dent in this multi-million-dollar market.